Ephrin receptor signaling, upregulated in sarcoidosis CD14 monocytes, has been an attractive therapeutic target for both infection and cancer (52) and has recently been investigated as a therapy for Inflammatory Bowel Disease (53). This evidence concerns the gene CD14 and infection.